Intermountain CISO: The industry needs better transparency after cyberattacks

The latest stories trending on MedCity News.

Editor's Pick

Top Story Intermountain Health CISO: The Industry Needs Better Transparency After Cyberattacks After a healthcare cyberattack, the impacted organization often doesn't want to divulge a lot of information, Intermountain Health CISO Erik Decker said last week at HIMSS. However, he thinks healthcare organizations should be more transparent with their peers after an attack because "no one system operates independent of everybody else." Sponsored Content Improving Patient Communication for Providers Presented by Artera and MedCity News Sarah Shillington, Chief Customer Officer with Artera, talked about how it is using the Harmony omnichannel platform to improve and organize care management to serve its 750+ provider customers. What Sectors Within Women's Health Are Being Neglected in Terms of Investment? "Health equity & chronic condition management. We have the worst infant and maternal outcomes in the developed world, and it's almost entirely due to social factors and chronic conditions that impact pregnancy. An emphasis on bridging social barriers and preventative care/chronic condition management specifically for women is needed." INVEST 2024 Speaker, Ellen Herlacher Partner of LRVHealth Register Now and Save $300 [ends 3/29]

Featured News

We Need Your Self-Insured Employer Health Benefits Insights for Our Annual Survey Do you advise self-insured employers? The 2023 Benefit Consultant Sentiment INDEX offered robust insights and cast a spotlight on the evolving roles of employers as they navigate the changing healthcare landscape. Your insights offer leading, innovative points of view that can guide employers and peers. Join us for this year's survey! Gene Therapy Is Now First FDA-Approved Treatment for Rare & Fatal CNS Disorder Orchard Therapeutics gene therapy Lenmeldy won FDA approval for treating the rare enzyme deficiency metachromatic leukodystrophy. In January, Kyowa Kirin completed its acquisition of Orchard, which now operates as a subsidiary of the Japanese drugmaker. Milu Health Raises $4.8M for AI-Driven Health Savings Platform Milu Health's $4.8 million seed round was led by Andreessen Horowitz (a16z) Bio + Health and included participation from BoxGroup, PagsGroup and 81 Collection. Healthcare Docket: Feds and States Move to Curb Private Equity's Takeover of Healthcare Will American healthcare go the way of the banking sector's consolidation into a handful of all-powerful titans? With MS & Fibrosis Trials Planned, J&J-Partnered Contineum Now Preps for IPO Contineum Therapeutics, which emerged from a Verant Ventures startup creation engine, has filed paperwork for an IPO. The biotech's clinical-stage pipeline spans multiple sclerosis, idiopathic pulmonary fibrosis, and depression. How Data and AI Help Pharma Sales Teams Better Market Precision Genetic Drugs As GenAI and other technologies advance the speed of development and the precision of drugs, pharma commercial teams need to make sure they are harvesting the right data with the right AI tools in order to ultimately reach the right patients.

Resources

MedCity Pivot Podcast: A Conversation with Lumen CEO Daniel Tal Mor In this episode of the MedCity Pivot Podcast, we looked deeper into Lumen, a consumer device meant to give people better understanding over how the body burns fat or carbs. We caught up with Daniel Tal Mor, CEO of Lumen, at Vive, and it was intriguing. What was the CEO of a direct-to-consumer company doing at an industry conference where the buyers were generally providers, employers and payers? Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe